Per employee per month spending on GLP-1 drugs increased 70% year-over-year from 2020-2024 for employers who covered them for weight loss and are part of the Healthcare Purchasers Alliance of Maine
doi: 10.3389/fendo.2025.1649270 Received 18 June 2025 Accepted 22 September 2025 Published 07 October 2025 Volume 16 - 2025 Edited by Lingling Wei, Capital Medical University, China Reviewed by Katy Sanchez-Pozos, Hospital Jurez de Mxico, Mexico Koyel Kar, BCDA College of Pharmacy and Technology, India brahim Sarbay, Gaziosmanpaa Training and Research Hospital, Trkiye Updates Copyright 2025 Gandecka-Pempera, Naskrt, Adamska and Zozuliska-Zikiewicz
Despite their effectiveness, GLP-1 therapies are not without limitations
However, studies of the functions of l- and d-carnitine in aquatic animals have yielded contradictory results to date ( Reference Santulli and DAmelio 23 , Reference Du, Liu and Tian 24 )
Theres no set schedule for follow-ups
News-medical.net